Toxicities of Immune Checkpoint Inhibitors: Itis-Ending Adverse Reactions and More

Immune checkpoint inhibitors (ICI) have revolutionized the treatment of cancer worldwide. Not long ago, before the introduction of ICIs, many cancers incurred a grave prognosis on patients due to the lack of effective therapies. For instance, patients with malignant melanoma survive longer and exper...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellithi, Moataz, Elnair, Radowan, Chang, Guy Vin, Abdallah, Mohamed A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067353/
https://www.ncbi.nlm.nih.gov/pubmed/32190487
http://dx.doi.org/10.7759/cureus.6935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067353/
https://www.ncbi.nlm.nih.gov/pubmed/32190487
http://dx.doi.org/10.7759/cureus.6935

Ejemplares similares